Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast

作者: S. K. Lee , J.-H. Yang , S.-Y. Woo , J. E. Lee , S. J. Nam

DOI: 10.1002/BJS.9337

关键词:

摘要: Background The aim of this study was to identify risk factors for invasive breast cancer in patients diagnosed with ductal carcinoma situ (DCIS) on a preoperative biopsy. These were used develop nomogram predicting the invasion setting. Methods This retrospective analysis who underwent surgical treatment DCIS before surgery between 1997 and 2009. Multivariable clinical, radiological histopathological that may predict upstaging. A developed probability using multiple logistic regression analysis. This subsequently validated another cohort diagnosis 2010 2012. Results Upstaging occurred 123 (24.9 per cent) 493 women treated larger lesion (at least 15 mm), lack hormone receptor expression, intermediate or high nuclear grade, core biopsy compared vacuum-assisted biopsy, non-cribriform subtype significantly associated these demonstrated good predictive performance (area under receiver operating characteristic (ROC) curve (AUC) 0·823, 95 cent confidence interval 0·787 0·860). The showed similar validation data set, based 149 (AUC 0·700, 0·613 0·786). Conclusion Upstaging is common. five most significant related upstaging accurately predicted cancer. be useful when deciding whether pursue axillary staging sentinel lymph node DCIS.

参考文章(34)
R. Sakr, C. Bezu, I. Raoust, M. Antoine, F. Ettore, J. Darcourt, K. Kerrou, E. Daraï, R. Rouzier, S. Uzan, The sentinel lymph node procedure for patients with preoperative diagnosis of ductal carcinoma in situ: risk factors for unsuspected invasive disease and for metastatic sentinel lymph nodes. International Journal of Clinical Practice. ,vol. 62, pp. 1730- 1735 ,(2008) , 10.1111/J.1742-1241.2008.01867.X
Nehmat Houssami, Daniela Ambrogetti, M. Luke Marinovich, Simonetta Bianchi, Petra Macaskill, Vania Vezzosi, Eleftherios P. Mamounas, Stefano Ciatto, Accuracy of a Preoperative Model for Predicting Invasive Breast Cancer in Women with Ductal Carcinoma-in-situ on Vacuum-Assisted Core Needle Biopsy Annals of Surgical Oncology. ,vol. 18, pp. 1364- 1371 ,(2011) , 10.1245/S10434-010-1438-9
P. Veronesi, M. Intra, A.R. Vento, P. Naninato, P. Caldarella, G. Paganelli, G. Viale, Sentinel lymph node biopsy for localised ductal carcinoma in situ? The Breast. ,vol. 14, pp. 520- 522 ,(2005) , 10.1016/J.BREAST.2005.08.007
Emil D Kurniawan, Allison Rose, Arlene Mou, Malcolm Buchanan, John P Collins, Matthew H Wong, Julie A Miller, G Bruce Mann, Risk Factors for Invasive Breast Cancer When Core Needle Biopsy Shows Ductal Carcinoma In Situ Archives of Surgery. ,vol. 145, pp. 1098- 1104 ,(2010) , 10.1001/ARCHSURG.2010.243
James A Eastham, Michael W Kattan, Peter T Scardino, None, Nomograms as predictive models. Seminars in Urologic Oncology. ,vol. 20, pp. 108- 115 ,(2002) , 10.1053/SURO.2002.32936
Melvin J. Silverstein, Kristin A. Skinner, Thomas J. Lomis, Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World Journal of Surgery. ,vol. 25, pp. 767- 772 ,(2001) , 10.1007/S00268-001-0003-X
Edna May L Go, Siu-Ki Chan, Joaquim S L Vong, Philip C W Lui, Anthony W H Chan, Tony K F Ma, Mark A Ang, Bonita K B Law, Puay-Hoon Tan, Gary M Tse, Predictors of invasion in needle core biopsies of the breast with ductal carcinoma in situ Modern Pathology. ,vol. 23, pp. 737- 742 ,(2010) , 10.1038/MODPATHOL.2009.187
Ning Liao, Guo-chun Zhang, Yan-hui Liu, Xue-rui Li, Meng Yao, Fang-ping Xu, Li Li, Yi-long Wu, HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in situ of the breast presenting extensive DCIS component Pathology Research and Practice. ,vol. 207, pp. 1- 7 ,(2011) , 10.1016/J.PRP.2010.08.005
Wai Ka Hung, Marcus Ying, Miranda Chan, Kong Ling Mak, Lap Kin Chan, The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ Breast Cancer. ,vol. 17, pp. 276- 280 ,(2010) , 10.1007/S12282-009-0164-2